Associate Director, HCP Marketing - Myositis

argenx is a global immunology company developing therapies for individuals living with autoimmune diseases. argenx is building a world-class portfolio of biologics in both early and late stages of development. VYVGART Hytrulo (efgartigimod), FDA approved for generalized Myasthenia Gravis (gMG) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and is being evaluated for additional indications including autoimmune myositis.

The Associate Director, US HCP Marketing will play an instrumental role in HCP marketing strategy and execution to support the upcoming VYVGART Hytrulo launch in autoimmune myositis. This is a high-impact role on a fast-paced and dynamic program.

This role will report to the Senior Director of US HCP Marketing, Rheumatology Lead, and will partner closely with key internal cross-functional partners and external agencies to plan and implement personal and non-personal tactics to support autoimmune myositis. In close collaboration with t...